IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behcet's disease

Kenji Yokota, Keiji Oguma

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The production of IgA protease in twelve strains of Streptococcus sanguis isolated from patients with Behcet's disease (BD) was examined. Protease activity was detected in 10 out of 12 strains. The protease was purified from one representative strain, S. sanguis 113-20, by employing Rotofor and DEAE-Sephacel chromatography. The molecular mass of the purified protease was approximately 100 kDa, and it cleaved the proline-threonine site of the IgA. Both IgG and IgA titers against the cells (113-20) and the purified IgA protease in the sera of BD patients and healthy controls, 36 each, were assayed. The IgG titers against the cells and protease were not significant in the BD patients or controls, but the IgA titers against the cells and protease in the BD patients were significantly higher than those of the controls. These data indicate that the BD patients are infected with IgA protease-producing S. sanguis strains, which cause an increase of IgA titer against these organisms and IgA protease antigen. Since the organisms can proliferate in BD patients for a long period of time (years), it seems that IgA antibodies cannot effectively eliminate the organisms.

Original languageEnglish
Pages (from-to)925-931
Number of pages7
JournalMicrobiology and Immunology
Volume41
Issue number12
Publication statusPublished - 1997

Fingerprint

IgA-specific serine endopeptidase
Streptococcus sanguis
Behcet Syndrome
Antibody Formation
Immunoglobulin A
Peptide Hydrolases
Immunoglobulin G
Threonine
Proline
Chromatography

Keywords

  • Behcet's disease
  • IgA protease
  • Streptococcus sanguis

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Microbiology (medical)
  • Microbiology

Cite this

IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behcet's disease. / Yokota, Kenji; Oguma, Keiji.

In: Microbiology and Immunology, Vol. 41, No. 12, 1997, p. 925-931.

Research output: Contribution to journalArticle

@article{dbd18e2c52754da4b0bfc8dc036c357c,
title = "IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behcet's disease",
abstract = "The production of IgA protease in twelve strains of Streptococcus sanguis isolated from patients with Behcet's disease (BD) was examined. Protease activity was detected in 10 out of 12 strains. The protease was purified from one representative strain, S. sanguis 113-20, by employing Rotofor and DEAE-Sephacel chromatography. The molecular mass of the purified protease was approximately 100 kDa, and it cleaved the proline-threonine site of the IgA. Both IgG and IgA titers against the cells (113-20) and the purified IgA protease in the sera of BD patients and healthy controls, 36 each, were assayed. The IgG titers against the cells and protease were not significant in the BD patients or controls, but the IgA titers against the cells and protease in the BD patients were significantly higher than those of the controls. These data indicate that the BD patients are infected with IgA protease-producing S. sanguis strains, which cause an increase of IgA titer against these organisms and IgA protease antigen. Since the organisms can proliferate in BD patients for a long period of time (years), it seems that IgA antibodies cannot effectively eliminate the organisms.",
keywords = "Behcet's disease, IgA protease, Streptococcus sanguis",
author = "Kenji Yokota and Keiji Oguma",
year = "1997",
language = "English",
volume = "41",
pages = "925--931",
journal = "Microbiology and Immunology",
issn = "0385-5600",
publisher = "Center for Academic Publications Japan",
number = "12",

}

TY - JOUR

T1 - IgA protease produced by Streptococcus sanguis and antibody production against IgA protease in patients with Behcet's disease

AU - Yokota, Kenji

AU - Oguma, Keiji

PY - 1997

Y1 - 1997

N2 - The production of IgA protease in twelve strains of Streptococcus sanguis isolated from patients with Behcet's disease (BD) was examined. Protease activity was detected in 10 out of 12 strains. The protease was purified from one representative strain, S. sanguis 113-20, by employing Rotofor and DEAE-Sephacel chromatography. The molecular mass of the purified protease was approximately 100 kDa, and it cleaved the proline-threonine site of the IgA. Both IgG and IgA titers against the cells (113-20) and the purified IgA protease in the sera of BD patients and healthy controls, 36 each, were assayed. The IgG titers against the cells and protease were not significant in the BD patients or controls, but the IgA titers against the cells and protease in the BD patients were significantly higher than those of the controls. These data indicate that the BD patients are infected with IgA protease-producing S. sanguis strains, which cause an increase of IgA titer against these organisms and IgA protease antigen. Since the organisms can proliferate in BD patients for a long period of time (years), it seems that IgA antibodies cannot effectively eliminate the organisms.

AB - The production of IgA protease in twelve strains of Streptococcus sanguis isolated from patients with Behcet's disease (BD) was examined. Protease activity was detected in 10 out of 12 strains. The protease was purified from one representative strain, S. sanguis 113-20, by employing Rotofor and DEAE-Sephacel chromatography. The molecular mass of the purified protease was approximately 100 kDa, and it cleaved the proline-threonine site of the IgA. Both IgG and IgA titers against the cells (113-20) and the purified IgA protease in the sera of BD patients and healthy controls, 36 each, were assayed. The IgG titers against the cells and protease were not significant in the BD patients or controls, but the IgA titers against the cells and protease in the BD patients were significantly higher than those of the controls. These data indicate that the BD patients are infected with IgA protease-producing S. sanguis strains, which cause an increase of IgA titer against these organisms and IgA protease antigen. Since the organisms can proliferate in BD patients for a long period of time (years), it seems that IgA antibodies cannot effectively eliminate the organisms.

KW - Behcet's disease

KW - IgA protease

KW - Streptococcus sanguis

UR - http://www.scopus.com/inward/record.url?scp=0031460303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031460303&partnerID=8YFLogxK

M3 - Article

C2 - 9492177

AN - SCOPUS:0031460303

VL - 41

SP - 925

EP - 931

JO - Microbiology and Immunology

JF - Microbiology and Immunology

SN - 0385-5600

IS - 12

ER -